MIST
Milestone Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · CA
$0.92
−0.41%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.20
- Revenue estimate
- $1.1M
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.21
- EPS estimate
- -$0.20
- Revenue actual
- $559.0K
- Revenue estimate
- $816.7K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -100.1%
- Revenue beats (12Q)
- 0
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $5.50
- PT range
- $3.00 – $8.00
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | -$0.20 | -$0.21 | Miss -7.69% | $559.0K |
| May 13, 2026 | $0.06 | -$0.20 | Miss -433.33% | — |
| Mar 20, 2026 | -$0.18 | -$0.16 | Beat 11.11% | $1.5M |
| Nov 12, 2025 | -$0.17 | -$0.12 | Beat 29.41% | — |
| Mar 13, 2025 | -$0.15 | -$0.19 | Miss -26.67% | — |
| Mar 21, 2024 | -$0.30 | -$0.32 | Miss -6.67% | -$868.0K |
| Nov 13, 2023 | -$0.38 | -$0.35 | Beat 7.89% | — |
| Aug 10, 2023 | -$0.39 | -$0.37 | Beat 5.13% | — |
| May 11, 2023 | -$0.38 | -$0.35 | Beat 7.89% | $1.0M |
| Nov 10, 2022 | -$0.41 | -$0.34 | Beat 17.07% | $1.5M |
| Aug 10, 2022 | -$0.36 | -$0.39 | Miss -8.33% | — |
| May 12, 2022 | -$0.39 | -$0.33 | Beat 15.38% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026